News for Spruce Biosciences Stock (SPRB)

IMPORTANT ACTION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/31/24

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/30/24

Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference

Business Wire • 05/23/24

Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society

Business Wire • 05/22/24

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/19/24

IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/17/24

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/16/24

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 05/15/24

Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research • 05/13/24

Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Business Wire • 05/13/24

Spruce Biosciences to Participate in May Investor Conferences

Business Wire • 05/01/24

Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting

Business Wire • 04/30/24

Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting

Business Wire • 04/22/24

IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 04/19/24

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB

PRNewsWire • 04/04/24

ONGOING SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 04/04/24

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 04/03/24

Spruce Biosciences (SPRB) Upgraded to Buy: Here's What You Should Know

Zacks Investment Research • 03/27/24

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire • 03/22/24

Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why

Zacks Investment Research • 03/21/24

Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Business Wire • 03/21/24

Why Is Spruce Biosciences (SPRB) Stock Down 78% Today?

InvestorPlace • 03/14/24

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. Incorporated and Encourages Investors with Losses to Contact the Firm

Accesswire • 03/14/24

Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates

Business Wire • 03/13/24

Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH

Business Wire • 03/13/24